Overall rank by patents
#1,157
Across all tracked assignees
USPTO PatentsView assignee record - 367 granted patents across 74 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS).
The verdict
Enplas holds 367 US patents across 74 technology areas, rank #1,157 of 50,000 tracked assignees.
Enplas Corporation has been granted 367 US utility patents between 2015 and 2025, placing Enplas Corporation at rank #1,157 across all assignees tracked by PlainPatent. This portfolio spans 74 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.1 claims per patent with primary concentration in G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS). As a Foreign Corporation, Enplas Corporation is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Enplas sits between St. Jude Medical, Atrial Fibrillation Division, Inc. (368 patents, rank #1,153) and Westinghouse Electric Company Llc (367 patents, rank #1,161) - the closest US assignees by grant volume. The composite Innovation Score of 55.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 178 grants, compared with 189 in the 2015–2019 window, a -6% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Enplas Corporation's 8.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 74 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Enplas Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
St. Jude Medical, Atrial Fibrillation Division, Inc.
368 patents
TRUSTEES OF DARTMOUTH COLLEGE
368 patents
YEDA RESEARCH AND DEVELOPMENT CO. LTD.
368 patents
Convida Wireless, LLC
367 patents
Kabam, Inc.
367 patents
Owens-Brockway Glass Container Inc.
367 patents
Rubrik, Inc.
367 patents
Westinghouse Electric Company LLC
367 patents
Enplas Corporation
367 patents
What this shows Enplas holds 367 patents at rank #1,157, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,157 in granted patent volume.
Other assignees with the most granted patents in Enplas's primary technology class.
Enplas's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
55 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 27 | 7.4% |
| 2016 | 42 | 11.4% |
| 2017 | 32 | 8.7% |
| 2018 | 38 | 10.4% |
| 2019 | 50 | 13.6% |
| 2020 | 51 | 13.9% |
| 2021 | 25 | 6.8% |
| 2022 | 35 | 9.5% |
| 2023 | 30 | 8.2% |
| 2024 | 26 | 7.1% |
| 2025 | 11 | 3.0% |
Top 15 of 74 technology areas
Overall rank by patents
#1,157
Across all tracked assignees
55.1 out of 100
How to use this portfolio
Enplas's 367 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.